Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013


Cell Culture

03 Jul 2013 - 04 Jul 2013 - London, UK



Bookmark and Share


SMi are pleased to announce their inaugural Cell-Culture conference taking place on the 3 & 4 July 2013 in London. The conference will feature an international expert speaking faculty discussing the latest developments in cell culture techniques from industry experts in the absolute cutting edge of their field.

Cell Culture is set to see huge increases in growth down to new techniques such as 3D cell culture moving to the fore. An industry set to be worth £4.5 billion driven by advances in pharma and biotech, working in collaboration with academia to provide some of the most important Cell-Culture methods for some time.

WHY ATTEND THIS EVENT:

• Focus with a range of leading speakers on 3D cell culture; learn how this method is revolutionising the field

• Hear about the latest techniques, technologies and methods being utilised in Cell-Culture

• Discover case studies on novel culture methods being developed on the International Space Station

• Explore new target identification and how to get your results earlier

• Learn from a wide array of international industry specialists


KEYNOTE SPEAKERS INCLUDE:

Timothy Hammond, M.B.B.S, Durham Veterans Medical Centre (Principle Investigator - NASA)

Katharine Cain, Senior Scientist, UCB

Anthony Davies, Director of the High Content Facility, Trinity College Dublin

Berthold Boedeker, Chief Scientist, Bayer

Kalpana Nayyar, Scientist I, MedImmune

Plus a Interactive Half-Day Pre-Conference Workshops on Tuesday 2nd July 2013 in London

Overcoming the challenges of moving from 2D to 3D Cell based assays 

in an HCS and HTS environment

Workshop Leader: Anthony Davies, Director, High Content

Book your place today: http://www.smi-online.co.uk/goto/cell-culture14.asp

Alternatively, contact Fateja Begum on tel: +44 (0)20 7827 6184 or email her on fbegum@smi-online.co.uk




Further information
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!